ARTICLE | Finance
Forbion’s European capital wave
Sticking to its strategy, firm raises $2.2B just 18 months after raising $1.5B
October 15, 2024 9:56 PM UTC
Forbion’s latest raise of €2.1 billion across two new funds — one being the largest ever biopharma fund raised in Europe — is a reminder that there’s still plenty of capital available for top-tier European biopharma innovations.
The speed at which the firm was able to deploy its prior funds sparked the new raise. In April 2023, Forbion raised a combined €1.4 billion ($1.5 billion) across two funds: the €750 million Forbion Ventures Fund VI and the €600 million Forbion Growth Opportunities Fund II. ...